| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.03 |